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Abstract
Background: Maternal Body Mass Index (BMI) is positively associated with infant
obesity risk. Breast milk contains a number of hormones that may influence infant
metabolism during the neonatal period; these may have additional downstream
effects on infant appetite regulatory pathways, thereby influencing propensity
towards obesity in later life.
Objective: To conduct a systematic review of studies examining the association
between maternal BMI and the concentration of appetite-regulating hormones in
breast milk.
Method: Pubmed was searched for studies reporting the association between
maternal BMI and leptin, adiponectin, insulin, ghrelin, resistin, obestatin, Peptide
YY and Glucagon-Like Peptide 1 in breast milk.
Results: Twenty six studies were identified and included in the systematic review.
There was a high degree of variability between studies with regard to collection,
preparation and analysis of breast milk samples. Eleven of fifteen studies reporting
breast milk leptin found a positive association between maternal BMI and milk leptin
concentration. Two of nine studies investigating adiponectin found an association
between maternal BMI and breast milk adiponectin concentration; however
significance was lost in one study following adjustment for time post-partum. No
association was seen between maternal BMI and milk adiponectin in the other
seven studies identified. Evidence for an association between other appetite
regulating hormones and maternal BMI was either inconclusive, or lacking.
Conclusions: A positive association between maternal BMI and breast milk leptin
concentration is consistently found in most studies, despite variable methodology.
Evidence for such an association with breast milk adiponectin concentration,
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however, is lacking with additional research needed for other hormones including
insulin, ghrelin, resistin, obestatin, peptide YYand glucagon-like peptide-1. As most
current studies have been conducted with small sample sizes, future studies should
ensure adequate sample sizes and standardized methodology.
Introduction
Early life nutrition is considered a key candidate modulator of feeding behaviour,
food intake and energy balance throughout life [1]. Evidence from a large number
of observational studies identifies the neonatal period as a critical time for the
long-term programming of adult health [2]. Meta-analyses indicate that
breastfeeding, as opposed to formula feeding, may protect against the
development of obesity and metabolic syndrome associated conditions in later life
[3–5], though other research suggests that the association between formula
feeding and obesity is explained by confounding [6]. Beneficial effects have been
hypothesised to derive in part from the action of bioactive components in breast
milk such as hormones [7]. To date, a number of hormones involved in the
regulation of energy homeostasis have been identified in breast milk; these include
leptin, adiponectin, insulin, ghrelin, resistin, obestatin, peptide YY (PYY) and
glucagon-like peptide 1 (GLP-1) [8–15]. In addition to having a direct influence
on infant appetite and weight gain, these peptides may also promote gut
maturation and the development of neuronal circuits in the central nervous
system that control metabolism. In this respect, hormones in breast milk may
have long-term metabolic repercussions for the offspring following early life
exposure [16].
In adults, the circulating concentration of these hormones are linked to an
individual’s body weight and BMI; leptin is secreted primarily by adipocytes in
proportion to the total amount of body adipose tissue, and is therefore positively
correlated with BMI [17], as is resistin [18]. The concentration of serum insulin
also increases with overweight and obesity [19]. In contrast, adiponectin [20],
ghrelin [21], obestatin [22] and PYY [23] correlate negatively with adiposity and
BMI, whilst the relation of GLP-1 with BMI is unclear [24]. Factors controlling
breast milk hormone concentrations are also unclear. Whilst leptin, ghrelin,
insulin and adiponectin have been speculated to pass from serum into breast milk
[25–28], the mammary gland is also capable of synthesising various hormones
[29, 30], potentially contributing to the quantity of hormone detected; the source
of the other hormones investigated remains to be established.
The objective of this systematic review is to examine the concentration of
appetite regulating hormones in breast milk, and their association with maternal
BMI. We hypothesise that the concentrations of these hormones in breast milk
correlate with maternal BMI.
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Subjects and Methods
Literature search
A search in PubMed (www.ncbi.nlm.nih.gov) for studies published before 04/09/
2014 in English was carried out using the following search terms and MEDLINE
Medical Subject Headings (MeSH) terms (milk, human [MeSH] OR breastmilk
OR ‘‘breast milk’’) AND (leptin OR adiponectin OR resistin OR insulin OR
ghrelin OR adipokine OR adipokines [MeSH] OR insulin [MeSH] OR ghrelin
[MeSH] OR obestatin OR Peptide YY [MeSH] OR Glucagon-Like Peptide 1
[MeSH]). The literature search was conducted by NJA, assisted by MJH. For
consideration into the systematic review the study must have included a report of
breast milk concentrations of any of the hormones; leptin, adiponectin, insulin,
ghrelin, resistin, obestatin, PYY and GLP-1, and their relation to maternal BMI,
including pre-, in- or post-pregnancy BMI.
Data extraction
Relevant studies were identified by evaluating the abstract, or by obtaining a full
copy of the article if the abstract was not available. Review articles and
commentaries were excluded. Reference lists of included articles were reviewed by
the authors to identify further relevant studies. Data extracted included date of
publication, number of participants, sample type, sample preparation method,
measurement technique, time of sample collection post-partum, mean, standard
deviation and range of maternal BMI, hormone concentration and the correlation
coefficient between maternal BMI and hormone concentration. Data were
independently verified by NJA and MJH and checked by CG. A PRISMA Checklist
[31] was also completed to assist in the reporting of this systematic review (S1
Table).
Quality of studies
A non-validated but pragmatic score by which to compare and measure the
quality of included studies was devised. This involved assessing whether the study
disclosed the type of sample analysed, whether maternal BMI was measured at the
time of sample collection, if time of sample collection was standardised and
adjustment was made for confounding factors and whether the study used
appropriate statistical analysis. Sample preparation was considered appropriate if
there was a centrifugation or sonication step prior to analysis. We considered that
some kind of sample preparation was required to get a true reading of the
hormone concentration, especially leptin. Previous research suggests that either
leptin is associated with milk fat globules [29]; therefore samples require
sonication in order to liberate leptin, or milk lipids interfere with the assays, so
centrifugation is required [32]. Whichever the case, sample preparation appears to
be needed in order to acquire accurate and reproducible readings. Sample size of
less than 50 participants was defined as small, 50–100 as medium, and above 100
as large. The score was derived by totalling the number of factors the investigators
Maternal BMI and Breast Milk Hormones
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had included and adding half a point for whether the study was small, one point
for a medium sized study, and 1.5 points for a large study.
Analysis of statistical methods used
As the concentration of hormones present in breast milk is non-normally
distributed, non-parametric statistical analysis, or analysis of log transformed data
was considered appropriate. Statistical significance was defined as a p value of
below 0.05.
Results
Identified studies
The literature search is outlined in Fig. 1. The search strategy identified 313
publications, with two further publications identified from reference lists.
Abstracts were screened for suitability; 259 studies were unsuitable and excluded
as breast milk hormone concentrations were not investigated. The full texts of 56
articles were reviewed; 30 studies were excluded after full-text review because they
did not report the correlation between maternal BMI and breast milk hormone
concentration, leaving 26 articles suitable for inclusion to the systematic review.
The publications identified used a range of different techniques for quantification
of hormone concentration, and reported concentrations over a wide range of time
throughout lactation (see Tables 1, 2, 3, 4 and 5 for further details). Table 6 gives
an overview of the quality of the studies included. Studies investigating hormone
concentrations in both colostrum and mature breast milk are evaluated. There
was not a large difference seen in the concentration of hormone between these
samples, however infants ingest significantly less colostrum than mature milk,
whether there is a different influence of breast milk hormones in colostrum
compared to mature milk is not known. Infants will ingest significantly greater
quantities of hormone in mature milk; however, it may be that hormones in in
colostrum are more active due to gut closure not having completed in colostrum
fed infants [33].
Leptin
Fifteen studies included a report of the correlation between breast milk leptin
concentration and maternal BMI [8, 12, 14, 34–45] (Table 1). In ten studies, a
positive correlation was reported at all time points measured [8, 14, 35, 38, 39, 41–
45]. In an additional study a positive correlation at 2–3 days post-partum was
found, but no correlation at six weeks post-partum [34]. In four studies no
correlation was found between breast milk leptin and maternal BMI at any time
point [12, 36, 37, 40]. In one study no correlation was identified between maternal
BMI and colostrum leptin concentration [36]. In four studies a positive
correlation was identified in the first two weeks of lactation between maternal
BMI and breast milk leptin concentration [34, 35, 38, 44], whilst in one study there
was no correlation at 15 days post-partum [37]. In five studies no correlation was
Maternal BMI and Breast Milk Hormones
PLOS ONE | DOI:10.1371/journal.pone.0115043 December 23, 2014 4 / 25
found at 1–3 months post-partum [12, 34, 36, 37, 40], whilst in six studies a
positive correlation was reported over the same period [14, 38, 39, 41–43]. In two
studies a positive correlation was found up to six months post-partum [44, 45],
whilst in a further study leptin concentrations were positively correlated with
maternal BMI throughout the lactation period, up to nine months post-partum
[39]. In one study no correlation was found at 12 months of lactation [36]. One
study did not specify at which point samples were collected post-partum, but
identified a positive correlation [8]. A negative correlation was not reported in
any study (Table 2).
Adiponectin
Nine studies include a report of the concentration of adiponectin in breast milk
and its association to maternal BMI [9, 36, 42, 45–50] (Table 3). Two studies
report a positive correlation between breast milk adiponectin and maternal BMI
[9, 50]. Woo et al [50] found a positive correlation between maternal BMI and
breast milk adiponectin concentration. Samples were collected longitudinally, and
due to a decrease in concentrations of adiponectin in samples collected later on in
lactation, adjustment was made for post-partum month and month of the year,
after which no correlation was observed. Martin et al [9] also reported a positive
association between maternal BMI and breast milk adiponectin concentration. In
seven studies, no correlation between maternal anthropometric measurements
and milk adiponectin was found [36, 42, 45–49]. Many of the studies that found
no correlation analysed colostrum rather than mature breast milk. Of the studies
in which no correlation was found, six involved the analysis of colostrum
[35, 36, 46–49]; in three studies samples were collected at 1–4 months post-
partum [42, 45, 47], and in one study samples were collected up to 12 months
post-partum [36].
Fig. 1. Flowchart of the search strategy used in the review. The relevant number of papers at each point is provided.
doi:10.1371/journal.pone.0115043.g001
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Insulin
Four studies were identified in which the concentration of insulin in breast milk
was measured, and the association with maternal BMI reported (Table 4). In two
studies a positive correlation was reported; in two further studies no correlation
was reported. Shehadeh et al [13] found no correlation on day three or day ten
post-partum. Fields et al [43] found no correlation at one month post-partum.
Ahuja et al [51] reported a positive correlation at six weeks post-partum whilst
Ley et al reported a positive correlation between maternal BMI and breast milk
insulin at three months post-partum, but not during the first week post-partum
[47].
Ghrelin
Aydin and colleagues conducted all three studies identified in which the
association between maternal BMI and breast milk ghrelin concentration was
assessed [10, 52, 53]. A correlation was not reported in any of these studies
(Table 5). In two studies, samples were collected at similar time points during the
first two weeks post-partum [10, 53]; whilst the third neglected to state the time
point post-partum in which samples were collected [52].
Resistin
A single paper by Savino et al in 2012 examined the association between maternal
BMI and breast milk concentration of resistin. The median time of collection was
80 days post-partum. Median breast milk resistin concentrations reported were
0.18 ng/mL, with an interquartile range of 0.44. The author reported there was no
correlation between breast milk resistin concentration and maternal anthropo-
metric measurements [12].
Obestatin
No studies were identified in which the association between maternal BMI and
breast milk obestatin concentration was examined.
Peptide YY
The association between breast milk concentration of peptide YY and maternal
BMI was evaluated in a single paper by Schueler et al [14], the researchers also
investigated breast milk leptin concentrations, and the study design is outlined in
Table 1. Protease inhibitors were added to the aliquot used for peptide YY
analysis. The researchers analysed peptide YY in both fore and hind milk, the
average concentration in fore milk was 39.5¡8.4 pg/mL (mean and standard
deviation), whilst the hind milk concentration was 38.9¡9.1 pg/mL at 4–5 weeks
post-partum, as analysed by RIA. The authors reported that there was no
correlation between maternal BMI and milk peptide YY.
Glucagon-like peptide 1
Concentrations of GLP-1 in breast milk were again investigated by Schueler et al
[14], in the only study identified to do so. The study design is outlined in Table 1,
protease inhibitor was used to preserve samples. In fore milk, the concentration of
Maternal BMI and Breast Milk Hormones
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GLP-1 was 12.7¡3.1 pM, whilst in hind milk it was 15.4¡3.1 pM (mean¡ SD).
Milk GLP-1 was analysed using RIA for total GLP-1. The authors reported no
correlation between maternal BMI and milk GLP-1.
Discussion
This systematic review, which includes 26 papers and samples from over 1000
participants, indicates that there is an association between the concentration of
leptin in breast milk and maternal BMI. Evidence for an association between
maternal BMI and other hormones investigated is either contradictory or
inconclusive. Inconsistencies in the data reported originate from the quality,
design and size of studies. In addition to heterogeneous study design, many
studies identified had small sample sizes, and hence limited power to detect
differences in the concentration of hormones between mothers with differing
BMI.
As BMI is not a direct measure of adiposity, the strength of the correlations
between these hormones and BMI may not reflect the true value of this
association. The increasing availability of more advanced techniques for
evaluating body composition may facilitate such studies in the future. For
example, to our knowledge, to date only one study has used dual X-ray
absorptiometry to assess maternal adiposity [14]. A further limitation is non-
standardised sampling; some studies involved analysis of either fore-milk or hind-
milk, some a whole breast expression, and in some the sampling technique was
not specified. This is potentially important as the concentration of hormones can
change over an expression from a single breast, during a single feed [44] and with
increasing duration of lactation [50]. Though this does not appear to be relevant
for leptin [44], it is unknown whether this is the case for other hormones. In the
majority of studies, samples were collected at a single time point, and those that
collected data at multiple time points did not attempt to evaluate or adjust for
time [42].
In regards to the methods of detection, predominantly immunoassay methods,
RIA or ELISA were used. These techniques resulted in similar values, so it is
unlikely that method of detection explains variability in the results obtained. More
likely, the method of sample preparation contributes to the different results
observed between different studies. In the majority of studies the supernatant of
centrifuged breast milk was analysed, whilst in some, whole milk was used without
prior treatment. There are conflicting recommendations about the most
appropriate method of sample preparation. Some suggest that milk lipid interferes
with the assays [32], whist others suggest it does not [8].
Many studies measured maternal BMI at different times during lactation or
pregnancy. There does not appear to be any consistent variation in results
obtained from studies measuring BMI at different time points, pre or post-
partum. This suggests the most appropriate time to correlate concentrations of
hormones in breast milk to maternal BMI is at the time of sample collection in
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PLOS ONE | DOI:10.1371/journal.pone.0115043 December 23, 2014 17 / 25
order to reflect current maternal adiposity and hence maximise the likelihood of
identifying an association. Furthermore, the time of sample collection could have
a significant impact on results obtained. This is because concentrations of
hormones change throughout the lactation period [50]. The majority of studies
accounted for this by collecting samples at a specific time point, and those that did
not adjusted for this effect [42].
Table 2 displays the associations observed by different studies over the study
period, all but one of these report consistent results over the study period. This
could be due to either a consistent biological observation, or the methods of the
studies being consistent.
Early nutrition may influence health outcomes in children and adults through
metabolic programming; breastfeeding is associated with altered adiposity in
infancy [54] and reduced overweight or obesity in later life compared to formula
feeding [55], but evidence of a causal association is uncertain. In the PROBIT
study, a cluster-randomized trial promoting breastfeeding, no difference was
found in adiposity measures at 11.5 years in two groups fed differing amounts of
breast milk [56]. Nonetheless, it is plausible that breast milk hormones might
mediate offspring metabolism and risk of later obesity. This would require the
presence of appetite regulating hormones in breast milk which retain their
biological activity following ingestion, and that they affect infant metabolism.
Supporting evidence comes from both human and animal models.
Previously, a positive correlation has been observed between maternal BMI,
weight and maternal serum leptin concentration [57]. This appears to be reflected
in breast milk, due to the positive correlation observed between breast milk leptin
concentration and maternal BMI. Infant serum leptin and maternal BMI have also
been shown to correlate, suggesting infants breast fed by mothers with a high BMI
are exposed to significantly higher quantities of leptin, which is subsequently
transferred to the infant bloodstream [58]. Infants born to obese mothers have
been shown to be more likely to become obese themselves [59]. Potentially, the
infant of the obese mother, who is ingesting an increased amount of leptin,
becomes leptin resistant and subsequently has impaired appetite regulation, with
an increased risk of obesity. Conversely increased leptin ingestion may enhance
satiety, reducing intake and later obesity. However, confounding influences must
be considered, such as the shared environment of mother and infant. Leptin
present in milk may provide a link between maternal body composition and
neonatal growth, development and energy balance. Further human studies have
found correlations between the growth of neonates and the concentration of
breast milk hormones [25, 39, 41].
Similarly to leptin, maternal serum adiponectin concentrations correlate with
maternal weight and BMI [60], also breast milk adiponectin has been reported to
be positively correlated with both maternal and infant serum adiponectin
concentrations [50, 60], although it is present at significantly lower concentrations
[27]. This suggests either the mammary epithelial cells are capable of synthesizing
adiponectin, or are able to transfer adiponectin from the blood.
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The quantity of adiponectin in breast milk may have biological implications for
the infant; negative correlations between breast milk adiponectin concentration
with infant and childhood adiposity have been found. Evidence demonstrates
adiponectin in breast milk is associated with a lower weight of the infant in the
first six months of life [61]. Furthermore, Luoto et al reported that colostrum
adiponectin concentrations were significantly higher in mothers whose offspring
were of normal weight at 10 years compared to mothers whose offspring were
overweight at 10 years [49]. Further supporting evidence is the recent
identification of adiponectin receptors in the human intestine [62]. The
correlations observed between breast milk adiponectin concentrations and infant
adiposity strengthens evidence suggesting there is an association between
breastfeeding and a reduced risk of obesity in adulthood. This suggests that breast
milk adiponectin is systemically absorbed in human infants, remains biologically
active and is capable of programing infant metabolism. However, important
confounding factors must be accounted for, as causality has not yet been
demonstrated, this association may be a reflection of the increased adiponectin
concentrations in normal weight mothers, who are more likely to have normal
weight children.
Physiological doses of orally administered human leptin have been demon-
strated to be absorbed into the bloodstream of nine day old rats [63]. Oral doses
of leptin have been shown to have demonstrable biological effects, affecting food
preference, body weight, i and reducing caloric intake and is capable of improving
insulin sensitivity [64–67]. Likewise, evidence suggests exogenous insulin is able to
be absorbed from the gut into the systemic circulation in rat models [68],
retaining its biological activity and potentially mediating effects on infant body
composition. In type 1 diabetic humans, all of the insulin present in the milk was
artificial, also insulin in human milk is present at comparable concentrations to
serum, suggesting there is an active transport mechanism [28]. Thus, current
evidence supports the possibility of an association between enteral absorption of
breast milk hormones with systemic effects, consistent with the hypothesis that
breast milk hormones are an important factor in the programming of infant
metabolism in the post-partum period [69].
The data presented here supports a correlation between increasing maternal
BMI and increasing breast milk leptin. In the majority of studies a positive
correlation between breast milk leptin and maternal BMI was found. In all but
two of the studies less than 100 participants were recruited. However, a large study
with 651 participants [42] demonstrated a strong association between maternal
BMI and breast milk leptin concentration.
A correlation was not found between adiponectin concentrations in breast milk
and maternal BMI. This is unexpected as in the serum of adults, adiponectin
concentrations are known to be inversely proportional to adiposity [20].
Therefore, it would be logical that overweight and obese mothers would have less
adiponectin present in their breast milk. In the study which did find an
association between maternal BMI and the concentration of adiponectin in breast
milk, a possible explanation is the association between adiponectin, prolactin and
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adiposity. Adiponectin is negatively correlated with prolactin [70], as prolactin
secretion is reduced in obesity, if adiponectin is produced by the adipose tissue of
the mammary gland, negative regulation by prolactin in more adipose women
could increase the concentration of adiponectin produced in the mammary tissue,
and secreted into breast milk. Although adiponectin in breast milk must be
regulated by factors other than maternal BMI, such as duration of breastfeeding
[50] and smoking status [42].
Evidence of a correlation between maternal BMI and breast milk insulin
concentration was inconclusive. This is also unexpected; research investigating the
breast milk of diabetic mothers found a direct correlation between serum and
breast milk insulin concentrations [71], and it is well documented that the
concentration of insulin in serum increases with increasing BMI, due to insulin
resistance [72]. One potential explanation is that included studies are under-
powered to detect this association.
With regard to ghrelin, conflicting results are also reported. Ghrelin can be
either acylated or de-acylated. The acylated form has caprylic acid attached to a
serine residue, and is commonly denoted as the active form, however, de-acyl
ghrelin has also been shown to have appetite stimulating effects [73]. Acylated
ghrelin is known to be particularly labile, and therefore it is especially important
to either acidify samples at collection, or use a protease inhibitor if attempting to
measure acylated ghrelin [74]. A positive correlation might be expected as the
serum concentration of active ghrelin is increased in obese compared to normal
weight patients [75], but this depends on the source of ghrelin found in breast
milk. There have been conflicting reports in regard to this, with both maternal
serum and mammary gland synthesis being suggested as the source of milk ghrelin
[10, 30]. Correlations have been observed between maternal serum ghrelin
concentration and breast milk ghrelin with infant serum concentrations,
suggesting breast milk is a source of ghrelin for the infant [76].
Resistin concentrations increase with obesity, therefore concentrations of breast
milk resistin might be expected to increase with maternal BMI. However, this
inference is not supported by the study undertaken by Savino et al in which no
correlation was found between maternal BMI and the concentration of resistin in
breast milk [12]. However, the small number of women included means the study
may be underpowered to examine this association.
Concentrations of both Peptide YY and Glucagon-like peptide 1 and their
association with maternal BMI were evaluated in a single study. Neither of these
hormones was found to have an association with maternal BMI. In regard to GLP-
1, no clear association between BMI and serum concentrations of this hormone
are yet to be established, therefore it is unsurprising an association was not
identified in milk, where the association is likely to be less pronounced. In regard
to PYY, where in serum, a negative association has been identified extrapolation
to the breast milk suggests that concentrations would be decreased in obese
mothers, unless there is another factor with a stronger influence on the
concentration of this hormone in breast milk.
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In summary, increasing maternal BMI is associated with an increase in the
concentration of leptin in breast milk. No evidence of a correlation between
maternal BMI and other hormones (adiponectin, insulin, ghrelin, resistin,
obestatin PYY or GLP-1) was found, but published data are limited and
interpretation problematic due to heterogeneity of study design, sample collection
and preparation, and the small number of participants. Improved understanding
of the potential of breast milk to influence offspring health requires that future
studies address these important methodological issues. Future studies should
ensure they are sufficiently sized, with a priori power calculations. Careful
attention should be paid to define methods of breast milk collection, specifying
whether fore and/or hind milk, or an entire expression was collected, and the use
of protease inhibitor to prevent break down of peptide hormones is recommended
[74]. Recording maternal BMI at time of sample collection is also recommended,
to best reflect current maternal adiposity. To control for potential diurnal
variations and changes over the course of lactation, sample collection should be
carried out at a consistent time and day post-partum.
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